1. Nivolumab in platinum-refractory head-and-neck cancers: A retrospective observational audit from a tertiary cancer center;Patil;Cancer Res Stat Treat,2022
2. Real-world evidence with nivolumab in head-and-neck cancer: Access is key!;Rajappa;Cancer Res Stat Treat,2022
3. Nivolumab for recurrent squamouscell carcinoma of the head and neck;Ferris;N Engl J Med,2016
4. Immune checkpoint inhibitors: Promising but still inaccessible treatment option for patients with head-and-neck cancer in India;Dhumal;Cancer Res Stat Treat,2022
5. Cancer care: Challenges in the developing world;Philip;Cancer Res Stat Treat,2018